{
    "clinical_study": {
        "@rank": "55544", 
        "brief_summary": {
            "textblock": "To assess the efficacy and safety of itraconazole oral solution in HIV-seropositive patients\n      with oropharyngeal candidiasis that is refractory to fluconazole."
        }, 
        "brief_title": "An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.", 
        "condition": [
            "Candidiasis, Oral", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Candidiasis", 
                "Candidiasis, Oral", 
                "HIV Seropositivity"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients receive itraconazole oral solution twice daily. Per 08/15/94 amendment, patients\n      with complete resolution of oropharyngeal candidiasis lesions upon completion of treatment\n      are eligible for maintenance treatment on protocol FDA 236C. Patients who decline\n      maintenance are followed for 6 weeks. Patients who relapse during follow-up are re-treated\n      for 14-28 days; if lesions clear, patients may enter the maintenance protocol."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n          -  HIV antibody seropositivity or diagnosis of AIDS.\n\n          -  Confirmed oropharyngeal candidiasis.\n\n          -  Failed fluconazole treatment within the past 14 days.\n\n          -  Life expectancy of at least 3 months.\n\n          -  NO symptoms of esophageal candidiasis (e.g., dysphagia) unless endoscopic exam of\n             esophagus was performed and fungal esophagitis was not present.\n\n          -  NO prior disseminated candidiasis.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms or conditions are excluded:\n\n          -  Underlying clinical condition that precludes study completion or places the patient\n             at significant risk.\n\n          -  Considered unreliable about following physician's directives.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Investigational drugs (approved expanded access drugs are permitted).\n\n          -  Rifampin.\n\n          -  Rifabutin.\n\n          -  Phenobarbital.\n\n          -  Phenytoin.\n\n          -  Carbamazepine.\n\n          -  Terfenadine.\n\n          -  Astemizole.\n\n        Patients with the following prior conditions are excluded:\n\n          -  History of hypersensitivity to imidazole or azole compounds.\n\n          -  Clinical evidence of significant hepatic disease within the past 2 months.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Investigational drugs within 1 month prior to study entry (approved expanded access\n             drugs are permitted)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002133", 
            "org_study_id": "236B", 
            "secondary_id": "ITR-USA-94"
        }, 
        "intervention": {
            "intervention_name": "Itraconazole", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Fluconazole", 
                "Itraconazole", 
                "Hydroxyitraconazole"
            ]
        }, 
        "keyword": [
            "Itraconazole", 
            "Acquired Immunodeficiency Syndrome", 
            "AIDS-Related Complex", 
            "Candidiasis, Oral"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35294"
                    }, 
                    "name": "Univ of Alabama at Birmingham"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Little Rock", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72205"
                    }, 
                    "name": "Univ of Arkansas for Med Sciences"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berkeley", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94705"
                    }, 
                    "name": "East Bay AIDS Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94115"
                    }, 
                    "name": "Kaiser Permanente Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20037"
                    }, 
                    "name": "George Washington Univ Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20422"
                    }, 
                    "name": "Veterans Administration Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20009"
                    }, 
                    "name": "Dr Douglas Ward"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46202"
                    }, 
                    "name": "Infectious Diseases Research Clinic / Indiana Univ Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bethesda", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "20892"
                    }, 
                    "name": "Natl Inst of Allergy & Infect Dis / Cln Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ann Arbor", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48105"
                    }, 
                    "name": "Ann Arbor Veterans Administration Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48201"
                    }, 
                    "name": "Wayne State Univ / Harper Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63108"
                    }, 
                    "name": "Washington Univ"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43210"
                    }, 
                    "name": "Ohio State Univ Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "73104"
                    }, 
                    "name": "Oklahoma City Veterans Administration Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19107"
                    }, 
                    "name": "Pennsylvania Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37212"
                    }, 
                    "name": "Infectious Disease Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78284"
                    }, 
                    "name": "Audie L Murphy Veterans Administration Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlottesville", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "22908"
                    }, 
                    "name": "Univ of Virginia Health Sciences Ctr"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "reference": {
            "citation": "Moskovitz B, Wu J, Baruch A, Benken C. Long term safety and efficacy of itraconazole oral solution (IS) for treatment of fluconazole refractory oropharyngeal candidiasis (OC) in HIV-positive patients (pts). Conf Retroviruses Opportunistic Infect. 1997 Jan 22-26;4th:124 (abstract no 325)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002133"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Janssen, LP", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 1996"
    }, 
    "geocoordinates": {
        "Ann Arbor Veterans Administration Med Ctr": "42.281 -83.743", 
        "Audie L Murphy Veterans Administration Hosp": "29.424 -98.494", 
        "Dr Douglas Ward": "38.895 -77.036", 
        "East Bay AIDS Ctr": "37.872 -122.273", 
        "George Washington Univ Med Ctr": "38.895 -77.036", 
        "Infectious Disease Clinic": "36.166 -86.784", 
        "Infectious Diseases Research Clinic / Indiana Univ Hosp": "39.769 -86.158", 
        "Kaiser Permanente Med Ctr": "37.775 -122.419", 
        "Natl Inst of Allergy & Infect Dis / Cln Ctr": "38.985 -77.095", 
        "Ohio State Univ Hosp": "39.961 -82.999", 
        "Oklahoma City Veterans Administration Med Ctr": "35.468 -97.516", 
        "Pennsylvania Hosp": "39.952 -75.164", 
        "Univ of Alabama at Birmingham": "33.521 -86.802", 
        "Univ of Arkansas for Med Sciences": "34.746 -92.29", 
        "Univ of Virginia Health Sciences Ctr": "38.029 -78.477", 
        "Veterans Administration Med Ctr": "38.895 -77.036", 
        "Washington Univ": "38.627 -90.199", 
        "Wayne State Univ / Harper Hosp": "42.331 -83.046"
    }
}